In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3.
D000818:Animals; D000918:Antibody Specificity; D003165:Complement System Proteins / Q000378:metabolism; D004912:Erythrocytes / Q000276:immunology; D006041:Goats / Q000276:immunology; D006168:Guinea Pigs; D006461:Hemolysis; D007106:Immune Sera; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D010527:Perissodactyla / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D012756:Sheep / Q000276:immunology; D012911:Snakes; D014688:Venoms / Q000494:pharmacology*
D007106:Immune Sera; D014688:Venoms; D003165:Complement System Proteins